The current pharma/bio market is a rapidly growing, high innovation market that has maintained exceptional growth over the past several years. Of the many technologies that have benefited from its rapid expansion, mass spectrometry has been at the forefront. The adoption of mass spectrometers has been particularly swift in proteomics and metabolomics applications. There are […]
The companies that manufacture the analytical instruments used in drug discovery and development are eyeing a market opportunity in the Contract Research Organization (CRO) industry. According to our latest report, the rush to develop new therapeutics in response to the COVID-19 pandemic has caused a flurry of activity in the pharma/bio sector, even as many […]
In modern times, Japan has been a haven for high technology, with its companies often paving the way for new technological advancements that help shape industries – such as innovations in robotics, semiconductors, and electronics. Although Japan remains a country of technological innovation and scientific research, current scientists in the country face hurdles in the […]
The last 6 months have been full of innovation and advancement for the mass spectrometry (MS) industry. As it’s one of the most dynamic branches of analytical instrumentation, even small technological improvements can vastly enhance the efficiency of analysis and spur growth.
June 14, 2021 1:52 pm
April 27, 2021 7:19 am
Strategic Directions International (SDi), part of Science and Medicine Group, is the leading business intelligence firm in the highly specialized field of analytical and life science instruments. Its client list includes virtually every major analytical instrumentation company in the United States, Europe, and Japan. Founded in 1981, the Los Angeles-based company has published hundreds of market reports and provided proprietary consulting services for a multitude of clients.